Unique Parallel Peptide Synthesizer with Automated Microwave Technology offers “The Best of Both Worlds” for Peptide Chemists

Unique Parallel Peptide Synthesizer with Automated Microwave Technology offers
“The Best of Both Worlds” for Peptide Chemists

Biotage, a leading supplier of tools and technology for medicinal and analytical
chemistry, today announced the eagerly awaited global launch of the Syro Wave™;
their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result
of the joint development project announced last year between Biotage and
MultiSynTech.  It combines the proven performance of the established
MultiSynTech robotic synthesizer with Biotage microwave technology.

The Syro Wave™ peptide synthesis system is the only system on the market that
offers both microwave and parallel peptide synthesis capabilities.  To date
peptide synthesis labs have been required to invest in both standalone parallel
systems for productivity and cost efficiency, and standalone microwave systems
for difficult or longer peptides.   This results in increased demand on bench
space, duplication of computer control systems, and multiple operating software
platforms for chemists to learn and maintain. Biotage has addressed these
shortcomings with the Syro Wave™, containing both parallel and microwave
technologies on the same platform.

The new Biotage Syro Wave™ increases productivity, yield and purity while
cutting costs and saving time.  “At Biotage the focus is on developing
technology to speed up and simplify experimental procedures while simultaneously
driving down operating costs.  Whether the customer is a Pharma development
group, a CRO focused on cost and productivity or an Academic researcher focused
on unique sequences, the Syro Wave™ fits.” noted Scott Carr, Vice President
Commercial Operations, Biotage. 

For more information on the Biotage parallel Peptide Synthesizer system, please
email product_info@biotage.com or visit www.biotage.com  

Contact:
Torben Jörgensen, CEO 
Phone: +46 18 56 59 02, 
torben.jorgensen@biotage.com


Om Biotage 
Biotage erbjuder lösningar, kunskap och erfarenhet inom analytisk kemi och
läkemedelskemi. Kunderna består bland annat av de största läkemedels- och
bioteknikbolagen i världen samt av ledande akademiska institutioner.
Huvudkontoret ligger i Uppsala och företaget har kontor i USA, England och
Japan. Biotage har 245 anställda och omsatte 394,1 MSEK under 2009. Biotage är
noterat på NASDAQ OMX Nordiska börsen i Stockholm. Hemsida: www.biotage.com